how does tirzepatide work vs semaglutide Retatrutide vs Semaglutide: Mechanism and Research Comparison Choosing Between Tirzepatide and Semaglutide

Zepbound is FDA-approved for chronic weight management

Furthermore, GLP-1 users have reported increased lean body mass and enhanced physical functioning

Adverse Reactions in Patients for Weight Reduction and Long-Term Maintenance Pool of Placebo-Controlled Weight Reduction Trials in Adults with Obesity or Overweight, with or without Type 2 Diabetes (Study 1 and Study 2) ZEPBOUND was evaluated for safety in a pool of two randomized, double-blind, placebo-controlled trials that included 2,519 adult patients with obesity or overweight treated with ZEPBOUND for up to 72 weeks and a 4-week off drug follow-up period (Study 1 and Study 2) [see Clinical Studies (14.1)]

Ann Thorac Surg 101(1):211-17, 2016